Susan C Fagan Selected Research

Susan C Fagan Research Topics

Disease

74	Stroke (Strokes) 02/2024 - 04/2003
42	Ischemic Stroke 12/2021 - 06/2003
27	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 04/2004
25	Infarction (Infarctions) 01/2019 - 01/2004
14	Ischemia 01/2019 - 08/2005
13	Brain Ischemia (Cerebral Ischemia) 10/2018 - 04/2004
12	Edema (Dropsy) 10/2017 - 08/2005
9	Cognitive Dysfunction 02/2024 - 02/2015
9	Hemorrhage 01/2021 - 09/2004
7	Hypoxia (Hypoxemia) 01/2019 - 06/2014
6	Reperfusion Injury 03/2017 - 08/2005
5	Inflammation (Inflammations) 05/2023 - 07/2006
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2005
5	Hypertension (High Blood Pressure) 01/2018 - 03/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 06/2011
4	Embolic Stroke 01/2019 - 10/2012
4	Brain Injuries (Brain Injury) 02/2018 - 04/2004
4	Cerebral Hemorrhage 10/2017 - 07/2010
4	Hyperglycemia 06/2015 - 06/2012
3	Atrial Fibrillation 06/2011 - 03/2004
2	Neuroinflammatory Diseases 01/2021 - 11/2013
2	Vascular Diseases (Vascular Disease) 01/2018 - 05/2015
2	Critical Illness (Critically Ill) 10/2017 - 01/2013
2	Pathologic Neovascularization 04/2015 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2015 - 01/2005
2	Neoplasms (Cancer) 09/2014 - 02/2010
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2013 - 09/2012
2	Diabetes Mellitus 10/2013 - 09/2004
2	Transient Ischemic Attack 06/2011 - 03/2004
2	Carotid Stenosis (Carotid Artery Stenosis) 06/2011 - 09/2004
1	Anhedonia 02/2024
1	Neurologic Manifestations (Neurological Manifestations) 12/2021
1	Optic Neuritis (Retrobulbar Neuritis) 10/2021
1	Dementia (Dementias) 06/2019

Drug/Important Bio-Agent (IBA)

23	candesartanIBA 01/2022 - 03/2006
19	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2018 - 06/2003
18	Minocycline (Cyclops)FDA LinkGeneric 10/2017 - 04/2004
12	compound 21IBA 02/2024 - 01/2015
11	Matrix Metalloproteinases (MMPs)IBA 01/2014 - 08/2005
9	Type 2 Angiotensin ReceptorIBA 02/2024 - 01/2015
8	Neuroprotective AgentsIBA 10/2021 - 04/2004
8	salicylhydroxamic acid (SHAM)IBA 11/2020 - 09/2008
8	Hemoglobins (Hemoglobin)IBA 10/2018 - 03/2006
7	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 12/2010
6	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2011
6	Angiotensin Receptor AntagonistsIBA 08/2018 - 09/2004
6	AngiotensinsIBA 01/2018 - 01/2014
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015 - 01/2011
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2011
5	Peroxynitrous Acid (Peroxynitrite)IBA 02/2018 - 06/2012
5	Biomarkers (Surrogate Marker)IBA 10/2017 - 10/2006
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 02/2013
4	Nerve Growth Factors (Neurotrophins)IBA 01/2017 - 02/2013
4	Metalloproteases (Metalloproteinases)IBA 03/2016 - 08/2010
4	Metformin (Glucophage)FDA LinkGeneric 05/2015 - 12/2010
4	AntioxidantsIBA 04/2015 - 01/2005
4	Warfarin (Coumadin)FDA LinkGeneric 09/2012 - 03/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2011 - 04/2004
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2011 - 03/2004
3	InflammasomesIBA 01/2019 - 04/2015
3	Type 1 Angiotensin ReceptorIBA 08/2018 - 01/2015
3	Blood Glucose (Blood Sugar)IBA 03/2016 - 08/2014
3	Peptide Hydrolases (Proteases)FDA Link 06/2012 - 04/2006
3	Tetracycline (Achromycin)FDA LinkGeneric 06/2011 - 04/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2011 - 02/2010
3	Clopidogrel (Plavix)FDA Link 06/2011 - 03/2004
3	Dipyridamole (Persantine)FDA LinkGeneric 06/2011 - 03/2004
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2011 - 04/2003
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2011 - 03/2004
2	IronIBA 01/2023 - 01/2021
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2023 - 01/2021
2	Drinking WaterIBA 01/2021 - 01/2020
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2019
2	Protective AgentsIBA 10/2017 - 08/2009
2	CytokinesIBA 03/2017 - 11/2013
2	Interleukin-10 (Interleukin 10)IBA 03/2017 - 11/2013
2	Small Interfering RNA (siRNA)IBA 10/2016 - 04/2015
2	3-nitrotyrosineIBA 10/2016 - 05/2015
2	Staphylococcal Protein A (Protein A)IBA 04/2015 - 04/2015
2	ThioredoxinsIBA 04/2015 - 04/2015
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2011 - 07/2010
2	Atorvastatin (Lipitor)FDA Link 01/2011 - 08/2009
2	AnticoagulantsIBA 09/2004 - 03/2004
2	triphenyltetrazoliumIBA 04/2004 - 01/2004
1	Fingolimod Hydrochloride (FTY720)FDA Link 10/2021
1	Hypnotics and Sedatives (Sedatives)IBA 06/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2019
1	Antidepressive Agents (Antidepressants)IBA 06/2019
1	Antipsychotic Agents (Antipsychotics)IBA 06/2019
1	Aquaporin 4IBA 01/2019
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2019
1	SiliconesIBA 01/2019
1	Vascular Endothelial Growth Factor BIBA 10/2018

Therapy/Procedure

20	Therapeutics 01/2020 - 06/2003
6	Sutures (Suture) 01/2019 - 09/2009
5	Thrombolytic Therapy 08/2014 - 07/2006
3	Glycemic Control 12/2013 - 01/2013
3	Secondary Prevention 06/2013 - 03/2004
3	Carotid Endarterectomy 06/2011 - 09/2004
2	Drug Therapy (Chemotherapy) 06/2019 - 03/2004